The topic of genesiology/eugenics may be ignored and considered morally reprehensible in modern society, but appears to be inevitable. I will ignore moral argument for this discussion.
The film Gattaca presents a vision of a future society driven by eugenics where potential children are conceived through genetic selection to ensure they possess the best hereditary traits of their parents. NASA has named Gattaca as the most accurate science fiction film of all time. Selective genesiology is inevitable.
This article reviews modern research aimed at making Gattaca the future. https://nerdist.com/20-year-anniversary-gattaca-genetics/ Some researches are quoted as saying genetic selection will be reality as soon as 5 years from now.
Gender and eye color can already be selected for with a procedure known as pre-implantation genetic diagnosis (PGD).
Key traits could include height and skin color. Susceptibility to cancer, heart disease, obesity, and genetic disease could also be on the table. Industries associated with these traits are already trillion dollar industries. Studies show height plays a major role in male social & financial success. Koreans and other asian culture pump millions into solutions to lighten their skin.
Related stocks:
CooperSurgical is a business unit of The Cooper Companies, Inc., a global medical device company. NYSE:COO
Editas Medicine is a biotechnology firm with a mission of using gene editing to treat disease. NASDAQ: EDIT
Other Links:
Over 5,000,000 babies have been born using IVF assisted technologies (which can allow for selection of eye color and gender) https://www.livescience.com/21355-5-million-babies-born-ivf-technologies.html
Gene replacement and repair with enzyme complex CRISPR/Cas9 Performed (this is the complex that allows for discovery of genes related to various diseases, even baldness, height, etc. These chinese researchers were able to actually change the genes) https://www.nature.com/news/chinese-scientists-genetically-modify-human-embryos-1.17378
Update on CRISPR patent legal battle between Editas Medicine (NASDAQ:EDIT) and CRISPR patent holder https://www.statnews.com/2018/04/27/crispr-patent-fight-round-two/
Podcast on Gattaca and the technology http://www.lifeofthelaw.org/2018/05/gattaca/
Grand View Research: PGT Market https://www.grandviewresearch.com/industry-analysis/preimplantation-genetic-testing-pgt-market
Grand View Research: Stem Cell Market https://www.grandviewresearch.com/industry-analysis/human-embryonic-stem-cell-market
Grand View Research: Expression Vectors Market https://www.grandviewresearch.com/industry-analysis/expression-vectors-market
Grand View Research: DNA Testing Market https://www.grandviewresearch.com/industry-analysis/dna-testing-market
Your thoughts
What are your favorite Biotechnology stocks that may shape the future of selective genesiology?